Skip to main content
Premium Trial:

Request an Annual Quote

Tamir Kazaz, Mark Smedley

Premium
Rosetta Genomics said this week that its CFO Tamir Kazaz has resigned to “pursue other interests.”
 
According to the company, a search has begun to find a replacement for Kazaz, who is expected to leave in the second half of 2008.
 

 
Invitrogen announced that Mark Smedley, the firm’s global head of operations, will lead the integration team for its $6.7 billion acquisition of Applied Biosystems.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.